Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1-infected individuals on prolonged effective antiretroviral therapy
- PMID: 10364365
- PMCID: PMC112674
- DOI: 10.1128/JVI.73.7.6099-6103.1999
Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1-infected individuals on prolonged effective antiretroviral therapy
Abstract
We have designed a novel, precise, and sensitive assay to measure unspliced (US) human immunodeficiency virus type 1 (HIV-1) mRNA in peripheral blood mononuclear cells of HIV-1-infected individuals by using real-time PCR and molecular beacons. Individuals were classified as either well suppressed (WS) or partially suppressed, based on longitudinal measurements of plasma HIV-1 RNA. The proportion of individuals with US mRNA undetectable over time was significantly higher among WS individuals; however, 30% of WS subjects still had detectable US mRNA after 24 months of effective antiviral therapy.
Figures





Similar articles
-
Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy.N Engl J Med. 1999 May 27;340(21):1614-22. doi: 10.1056/NEJM199905273402102. N Engl J Med. 1999. PMID: 10341273 Clinical Trial.
-
Human immunodeficiency virus type 1 RNA in peripheral blood mononuclear cells of patients receiving prolonged highly active antiretroviral therapy.J Infect Dis. 2001 Nov 15;184(10):1341-4. doi: 10.1086/324002. Epub 2001 Oct 2. J Infect Dis. 2001. PMID: 11679927
-
Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.JAMA. 1999 Nov 3;282(17):1627-32. doi: 10.1001/jama.282.17.1627. JAMA. 1999. PMID: 10553788
-
Residual human immunodeficiency virus type 1 infection in lymphoid tissue during highly active antiretroviral therapy: quantitation and virus characterization.AIDS Res Hum Retroviruses. 2001 May 1;17(7):577-86. doi: 10.1089/088922201300119671. AIDS Res Hum Retroviruses. 2001. PMID: 11375053
-
Antiretroviral therapy in human immunodeficiency virus-infected individuals.Adv Intern Med. 1998;43:373-402. Adv Intern Med. 1998. PMID: 9506188 Review. No abstract available.
Cited by
-
Memory CD4+ T cells that co-express PD1 and CTLA4 have reduced response to activating stimuli facilitating HIV latency.Cell Rep Med. 2022 Oct 18;3(10):100766. doi: 10.1016/j.xcrm.2022.100766. Epub 2022 Oct 4. Cell Rep Med. 2022. PMID: 36198308 Free PMC article.
-
Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy.J Clin Invest. 2000 Oct;106(7):839-45. doi: 10.1172/JCI10565. J Clin Invest. 2000. PMID: 11018071 Free PMC article.
-
Nuclear localization of human immunodeficiency virus type 1 preintegration complexes (PICs): V165A and R166A are pleiotropic integrase mutants primarily defective for integration, not PIC nuclear import.J Virol. 2002 Nov;76(21):10598-607. doi: 10.1128/jvi.76.21.10598-10607.2002. J Virol. 2002. PMID: 12368302 Free PMC article.
-
Rapid detection of herpes simplex virus DNA in genital ulcers by real-time PCR using SYBR green I dye as the detection signal.J Clin Microbiol. 2002 Mar;40(3):1060-2. doi: 10.1128/JCM.40.3.1060-1062.2002. J Clin Microbiol. 2002. PMID: 11880439 Free PMC article.
-
HibeRNAtion: HIV-1 RNA Metabolism and Viral Latency.Front Cell Infect Microbiol. 2022 Jun 14;12:855092. doi: 10.3389/fcimb.2022.855092. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35774399 Free PMC article. Review.
References
-
- Chun T W, Finzi D, Margolick J, Chadwick K, Schwartz D, Siliciano R F. In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. Nat Med. 1995;1:1284–1290. - PubMed
-
- Chun T-W, Carruth L, Finzi D, Shen X, DiGiuseppe J, Taylor H, Hermankova M, Chadwick K, Margolick J, Quinn T, Kuo Y-H, Brookmeyer R, Zeiger M, Barditch-Crovo P, Siliciano R. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature. 1997;387:183–188. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical